Table 3

Surgical Treatments and Outcomes after Inguino-femoral Lymph Node Dissection (ILND)

Fibrin sealant group n = 16
 Control group n = 14


Variable
 No.
 % of total
 No.
 % of total
 P value
Surgical Treatment




Patients undergoing superficial ILND
 9
 56
 11
 79
 0.26
Patients undergoing superficial + deep ILND
 7
 44
 3
 21
Median length of surgery, minutes (range)
 227
(95–455)
261
(96–713)
0.53
Median estimated blood loss, mL (range)
 50
(0–300)
75
(0–1075)
0.75
Median No. lymph nodes removed (range)
 17.5
(9–56)
15
(9–38)
0.07
Median No. positive lymph nodes (range)
 3
(1–12)
2
(0–21)
0.41
Patients undergoing concurrent limb perfusion
 0
 0
 2
 14
 0.21
Outcomes




Median time to drain removal, days (range)
 31
(11–45)
26
(13–74)
0.59
Patients with clinically evident seroma
 3
 19
 3
 21
 1.00
Patients with clinically evident seroma requiring drainage
 3
 19
 2
 14
 1.00
Patients with wound infection
 7
 44
 7
 50
 0.73
     Major (inpatient management)
 3
 19
 2
 14
 1.00
     Minor (outpatient management)
 4
 25
 5
 36
 0.69
Patients with wound dehiscence
 7
 44
 5
 36
 0.65
     Major (inpatient management)
 1
 6
 0
 0
 1.00
     Minor (outpatient management)
 6
 38
 5
 36
 0.92
Patients with drain issues




No., number
 1
 6
 3
 21
 0.32

Mortenson et al. World Journal of Surgical Oncology 2008 6:63   doi:10.1186/1477-7819-6-63